Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
14 drugs in development
By Therapeutic Area
top 5
R&D Momentum
81/100
Pipeline Velocity
53/100
Trial Completion Rate
67/100
Pipeline Concentration
34/100
Pipeline Freshness
33/100
Strategic Signals
Activity
Last 14 days
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Innovative Therapy to Treat Women With Angina With Nonobstructive Coronary Artery Disease (ANOCA) and Coronary Microvascular Disease
A Randomized Clinical Trial of Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)